We are reformulating existing approved compounds using innovative technologies or using scientific approach to the modification of existing API of approved compounds that has the potential to save lives or improve the quality of life for our patients. Our platform technology can be used for improving the characteristics of existing approved drugs for several indications. We are actively seeking partners who can commercialize our compounds and bring them to patients. Our current focus is on compounds addressing patient needs in CNS, Oncology and Pain indications.

Additional information see the attached tear sheet .Click here to download If interested, please contact